Cholesterol lowering drugs linked to improved gut bacteria composition in obese people
3 institutional releases
Published in Nature · View the paper (DOI)
Research finds that statin drugs may modulate disrupted gut microbiota and inflammation in obesity, with improved Bact2 enterotype composition in treated individuals compared to non-treated counterparts. Statin therapy may also have anti-inflammatory effects via improvement of an aberrant gut microbiota.
Coverage from 3 institutions
- Cholesterol lowering drugs linked to improved gut bacteria composition in obese people University of Copenhagen - The Faculty of Health and Medical Sciences · May 6, 2020 · first to report
- Obesity is linked to gut microbiota disturbance, but not among statin-treated individuals VIB (the Flanders Institute for Biotechnology) · May 6, 2020
- Improved gut microbiota with cholesterol-lowering medication University of Gothenburg · Jun 15, 2020